High-resolution 18F-FDG PET with MRI for monitoring response to treatment in rheumatoid arthritis
verfasst von:
Abhijit J. Chaudhari, Spencer L. Bowen, George W. Burkett, Nathan J. Packard, Felipe Godinez, Anand A. Joshi, Stanley M. Naguwa, David K. Shelton, John C. Hunter, John M. Boone, Michael H. Buonocore, Ramsey D. Badawi
This work was funded by the NIH grants UL1-RR024146, R01CA129561, R01EB002138 and the UC Davis Imaging Research Center.
Molecular imaging can potentially provide means for monitoring response to therapy in rheumatoid arthritis (RA) early in the course of disease [1].Quantitative measurements of RA disease activity made in the wrist by whole-body PET scanners, however, have inadequate accuracy because of limited spatial resolution [2]. A high-resolution PET/CT scanner for imaging extremities has been built at our institution [3]. In conjunction with a clinical MRI scanner, high-resolution PET/MR images can be obtained for the wrist. The CT image is used for PET/MR image coregistration.
A 57-year-old female with established RA was stable until a recent clinical flare-up in the right wrist. Clinical examination revealed synovitis, swelling, and diminished range of motion. The patient also had a history of osteoarthritis (OA). An extremity 18F-FDG PET/CT scan immediately following MRI at baseline was performed on this patient. Tumor necrosis factor alpha (TNF-α) inhibitor (etanercept) therapy was then initiated as a part of the patient’s standard of care. The patient was re-scanned 5 weeks after starting treatment.
Anzeige
The figure shows high-resolution 18F-FDG PET images (pseudocolor) overlaid on pre-contrast MRI images (gray scale) at baseline (left column) and 5 weeks (right column). Significant reduction in PET signal (suggesting reduced inflammation) in the synovium and at sites of erosions (white arrows) is visible. The green arrow shows inflammation due to OA. Physician examination at 3 months confirmed that this patient responded positively to etanercept. This case illustrates the potential of high-resolution PET with MRI for quantitative visualization of early response to therapy in RA.
×
Open Access
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Open AccessThis is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License (https://creativecommons.org/licenses/by-nc/2.0), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Mit e.Med Radiologie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Radiologie, den Premium-Inhalten der radiologischen Fachzeitschriften, inklusive einer gedruckten Radiologie-Zeitschrift Ihrer Wahl.
High-resolution 18F-FDG PET with MRI for monitoring response to treatment in rheumatoid arthritis
verfasst von
Abhijit J. Chaudhari Spencer L. Bowen George W. Burkett Nathan J. Packard Felipe Godinez Anand A. Joshi Stanley M. Naguwa David K. Shelton John C. Hunter John M. Boone Michael H. Buonocore Ramsey D. Badawi
